QBC Diagnostics Now Listed on GSA Advantage! ®
PORT MATILDA, Pa., Nov. 13, 2012 /PRNewswire/ -- QBC Diagnostics, a global manufacturer of hematology and infectious disease diagnostics equipment, announced today that the company's U.S. General Services Administration (GSA) Schedule 66 Contract for Scientific Equipment and Services is now publicly available online through the GSA Advantage! ® website.
With GSA Advantage! ® Federal employees are able to research, compare, and purchase a complete range of products and services all on one centrally located website. GSA's Scientific Equipment and Services Schedule 66 Contract, which QBC Diagnostics was awarded earlier this year, specifically provides federal agencies with scientific instruments for uses such as public safety, medical research, and laboratory diagnostics. Under contract number GS-07F-0306Y, QBC Diagnostics has been approved to sell to government agencies for all of their major product lines, including the QBC STAR Hematology Analyzer and the QBC ParaLens Advance Fluorescence Microscopy Attachment.
"We're always looking for ways to improve our customer experience and make it that much easier for them to secure the products they need in a timely manner," said Craig Stout, QBC Diagnostics' General Manager and Vice President. "By adding our products to GSA Advantage! ® we've taken the next step forward by providing federal employees a convenient and easy way to purchase our products."
QBC Diagnostics provides a number of innovative point-of-care diagnostic devices to U.S. government agencies worldwide. The QBC STAR Hematology Analyzer is the world's premier dry hematology analyzer, and is currently installed on over 250 U.S. Navy vessels, including both surface and submarine forces. Working closely with the U.S. Department of State, QBC Diagnostics also provides hematology solutions to more than 50 United States Embassies. In addition to hematology products, QBC also offers the ParaLens Advance, a cutting-edge fluorescence microscopy attachment which provides any standard light microscope with fluorescence capability. Presently the ParaLens Advance can be found in a number of National Tuberculosis Programs around the globe.
About QBC Diagnostics
QBC Diagnostics is a privately held company headquartered in Port Matilda, Pennsylvania. The company manufactures a line of complete blood count analyzers and fluorescence microscopy products. Additional information can be found by visiting the company website (www.qbcdiagnostics.com) or by calling +1-814-692-7661. Follow QBC on Facebook or Twitter for further updates.
SOURCE QBC Diagnostics